{"name":"Vaxxinity","slug":"vaxxinity","ticker":"VAXX","exchange":"NASDAQ","domain":"vaxxinity.com","description":"Vaxxinity is a biotechnology company focused on developing synthetic biology-based vaccines. The company's pipeline includes several candidates targeting various therapeutic areas. Vaxxinity has a strong presence in the vaccines sector, with a growing portfolio of products.","hq":"Dallas, TX","founded":0,"employees":"","ceo":"Mei Mei Hu","sector":"Vaccines / Synthetic Biology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$180M","metrics":{"revenue":5000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":35899000,"netIncome":-56934000,"cash":44311000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"VAXZEVIA patent cliff ($X.XB at risk)","drug":"VAXZEVIA","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"BNT162b2 vaccine","genericName":"BNT162b2 vaccine","slug":"bnt162b2-vaccine","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"ChAdOx1-S vaccine","genericName":"ChAdOx1-S vaccine","slug":"chadox1-s-vaccine","indication":"COVID-19 prevention (Phase 3 development)","status":"phase_3"},{"name":"Sinopharm BIBP","genericName":"Sinopharm BIBP","slug":"sinopharm-bibp","indication":"COVID-19 prevention in adults and pediatric populations","status":"phase_3"}]}],"pipeline":[{"name":"BNT162b2 vaccine","genericName":"BNT162b2 vaccine","slug":"bnt162b2-vaccine","phase":"marketed","mechanism":"Not specified","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age"],"catalyst":""},{"name":"ChAdOx1-S vaccine","genericName":"ChAdOx1-S vaccine","slug":"chadox1-s-vaccine","phase":"phase_3","mechanism":"ChAdOx1-S is a viral vector vaccine that delivers the SARS-CoV-2 spike protein gene to stimulate adaptive immune responses against COVID-19.","indications":["COVID-19 prevention (Phase 3 development)"],"catalyst":""},{"name":"Sinopharm BIBP","genericName":"Sinopharm BIBP","slug":"sinopharm-bibp","phase":"phase_3","mechanism":"Sinopharm BIBP is a COVID-19 inactivated vaccine that stimulates immune responses against SARS-CoV-2 by presenting inactivated viral particles to the immune system.","indications":["COVID-19 prevention in adults and pediatric populations"],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Vaxxinity Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Vaxxinity reported its financial results for the fourth quarter and full year 2023, with revenue of $X.X million and a net loss of $Y.Y million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Vaxxinity Announces Collaboration with [Partner] to Develop Synthetic Biology-Based Vaccines","summary":"Vaxxinity entered into a collaboration with [Partner] to develop synthetic biology-based vaccines targeting various therapeutic areas.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPaDJfUVNaVlI4REpUalM1aGVJc0pPOGFUV0xneUtzZEFaaXJzNkxsZHR4TGdNMnk2aFRCVTlzUzNvWjkzQV9qSUlhNUJGZ3VoSVZnQVh5QkgtZDljcEZVSVFqd1RpbG5sMjV1VG81cjFnNWZaQU1ZOGhLZXFJYTJhcFNoS0VWNGREeFRWOEh1OFd3TUdnS2trNE9B?oc=5","date":"2025-05-28","type":"pipeline","source":"Pharma Voice","summary":"With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon - Pharma Voice","headline":"With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxORFhTNTB0R3JkQXhPT05IVzJkNXUtaWlWMHFKbUpxakpQalNpcHdjeExQQjRVcDBlbDZYTGRJUkNPMEgwcXR4RURreGhmOXNHSG1CUlRxOEJLRmNRcHVfb2FOTUd2VnM0OGlLVmpDRTdVbWFLZmNMeWFnckV1eFV1ODNVZDhZRHc5VFFnQUFpM1lmNHFWYU5VY0ozY2hOY3RhNXpXSk81NnluWFFmaHdNcnRDdkZwUWxSQ2dxNHdHNA?oc=5","date":"2024-08-27","type":"pipeline","source":"New Scientist","summary":"How a new kind of vaccine could lead to the eradication of Alzheimer's and dementia - New Scientist","headline":"How a new kind of vaccine could lead to the eradication of Alzheimer's and dementia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE96QzctMVVrVkdSdlNNanFSN1pxOE5HMG1tbVl1b2VzVGhFd1ExUV93enRucVNGalZvQlNJTW9ZMF80NmRSTlo3OWpIQTdUb0NlSkVvWWxkRGR1RHBCQnRJRnR1am13QQ?oc=5","date":"2024-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Vaxxinity - The Pharma Letter","headline":"Vaxxinity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBKZlZmZ1hoYi02VzRYcC1fQzJqdTRXMTVEMkxJOUM2c0tqbnhkYWVwdnhYZTByRnFJMG00dnhsbHV2UEh1TWl1bTBhaTJJWk9wanowTnkwU2Y?oc=5","date":"2024-05-12","type":"pipeline","source":"TradingView","summary":"VAXX Stock Price and Chart — OTC:VAXX - TradingView","headline":"VAXX Stock Price and Chart — OTC:VAXX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOckh1dWs3a3pRWTVwR19JaXhMYVZmSXhXUWZUQnkzbzUtbTQ1NWRFRDFiNF9mVUxJZnM0cFRYWWlDOGRJcHpjeVhfTE9YOGtJXzZpMkMtdUtLZVYyVzlYYWcxMFZ1OW5qUklGZnd1V2RwS2Z4dHBuTXBfVGM4Njc1X3JhbzdOdlFRdXNDQ2drckNPU1E?oc=5","date":"2024-04-22","type":"pipeline","source":"InvestorPlace","summary":"Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today? - InvestorPlace","headline":"Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOaWltYjNLUG00VTlqY192WG12eW9Mbm5uQzE1T3o5X3dOc1E1MmlJNGtnb0VSeU5fVHpZUnhfek9BMGNyZkYtQmRMUTZjckRSUWxhSmVsaEc1eEs3a3NvM1RwSkY1V3lKZjY1d1pNLWVSNTFEN2M1cTEzNkVTVGxxcmptZ1dmWnVkRl9JUTRxb2kxTElVRDMtcjJ6VzA?oc=5","date":"2024-04-22","type":"pipeline","source":"InvestorPlace","summary":"Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts - InvestorPlace","headline":"Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts","sentiment":"neutral"},{"date":"2024-04-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-03-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2024-03-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8K","headline":"SEC 8-K: FORM 8K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNdlE3TVBISndnMlFMaW12LXpUTkJYd092Zmg4aE1EXzFURk1vekQ5WktkZUJQUzk3Wm5xUXJCNU9XZXU5UTFoOUtpOS0xOENzVlJCWlpFYjIyTThKMnZ3dHlCZzRKYmJPaFdwT0g1Z3gyb2xDVy0xWTYwdkRQemtoU0lGcExfTWxsaFByLWw3V2dhR2FiM19kbks1ZmNxQXFZbFFSd3dkbk81TW9QZ1ZHZUI0SnpQT1U?oc=5","date":"2024-03-08","type":"trial","source":"Pharmaceutical Technology","summary":"AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine - Pharmaceutical Technology","headline":"AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine","sentiment":"positive"},{"date":"2024-02-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxORUNaREJDSHJLYlVXVEhFQktRcmNLbTN4cmxINjl2YkJPVDc0QjE2UllfbHNmZW8xT2RzcDZyYlEzdnp2VnFrZm5Rd19yQ3k3MktPbFMxcko2OFk3dXhCc1ZDYVcyejNiQkM3QWpuMXE5clM5R1pDay1LcXVJcE9FakN0RUJhQ0ZyMzg4U19Ha0hqOVE?oc=5","date":"2024-02-05","type":"pipeline","source":"Pharma Voice","summary":"Vaxxinity is brewing up meds for a spacefaring future - Pharma Voice","headline":"Vaxxinity is brewing up meds for a spacefaring future","sentiment":"neutral"},{"date":"2023-12-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQYlVZYUo2cEJoNUJad2p2SXFPQ1hnNHI5aE1hM3lfR0dQaUxLZmRzU3ptNV9yUU9LWHBZTC1EMFdqYUxHcjF3YllUWS1CaXNxdVhzVjJwV1hPcFdvZVAwUXJyVXRJa25LbXFFLXlyX09sWlhhckpfUHN2WGl2QldVLXBKRFU2d1B3MDhCVzRKUXVsR1FYMWVEZ0RhejE5QkljbTdETkl0UnZNcGtLazBpNkNXV1ZkZ0FNaXcxdFpUZDg2akxxQUJtakRXSWE4a2xtaE1sNWNyMA?oc=5","date":"2023-11-20","type":"pipeline","source":"Reuters","summary":"Focus: Researchers return to Alzheimer's vaccines, buoyed by recent drug success - Reuters","headline":"Focus: Researchers return to Alzheimer's vaccines, buoyed by recent drug success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRC1EN0ljYk1MZHRtM1JoanlRMlFGQVNWSlRSTXBtX1lJdlV5Ykc1cm5MeVZzTTlUYVVqTThKOXB6dE1PdzhRTlZLVmtFVTlqMlJXYTNkdjJlMkxBTXF6NXF3cGNvQ2lqT25kNF9lZENIaGdiSnFTT2k2dUxzOWRTR2pGc05LcndG?oc=5","date":"2022-01-14","type":"pipeline","source":"Pharma Voice","summary":"Vaxxinity looks to pioneer the next revolution in pharma - Pharma Voice","headline":"Vaxxinity looks to pioneer the next revolution in pharma","sentiment":"neutral"}],"patents":[{"drugName":"VAXZEVIA","drugSlug":"covid-19-vaccine","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US"}],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Moderna Therapeutics","BioNTech SE","Pfizer Inc."],"therapeuticFocus":["Infectious Diseases","Synthetic Biology"],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":0,"period":"2022-12-31"},{"value":66000,"period":"2021-12-31"},{"value":66000,"period":"2021-12-31"},{"value":557000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":35899000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-56934000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":44311000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}